Author:
Triller Darren M.,Evang Samuel D.,Tadrous Mina,Yoo Bong Kyu
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy,General Medicine,Pharmacology (medical),Pharmacology
Reference31 articles.
1. Approval Letter. http://www.fda.gov/cder/foi/nda/2007/021985s000_APPROV.pdf Accessed on 23 June 2008.
2. Pharmacology Review Part 2. http://www.fda.gov/cder/foi/nda/2007/021985s000_PharmR_P2.pdf Accessed on 23 June 2008.
3. Pharmacology Review Part 3. http://www.fda.gov/cder/foi/nda/2007/021985s000_PharmR_P3.pdf Accessed on 23 June 2008.
4. Wood JM, Maibaum J, Rahuel J, Grutter MG, Cohen NC, Rasetti V, et al. Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochem Biophys Res Commun. 2003;308:698–705. doi: 10.1016/S0006-291X(03)01451-7 .
5. Stanton A, Jensen C, Nussberger J, O’Brien E. Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension. 2003;42:1137–43. doi: 10.1161/01.HYP.0000101688.17370.87 .
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献